Synnovation Therapeutics launches with $102M

WILMINGTON – A precision oncology startup based out of the Experimental Station in Wilmington has emerged with $102 million financing last week. Synnovation Therapeutics, led by CEO Wenqing Yao, completed Series A funding round led by Third Rock Ventures. The investment also included funds from Nextech, Lilly Asia Ventures, Sirona Capital and Cormorant Asset Management.